September 1, 2014

Subscriber Login

Online Subscription

Online Subscription Options

Attorney General Conway applauds FDA for adding warnings to opioid painkillers about the dangers of use during pregnancy

FDA takes action after request from AG Conway

Attorney General Conway today applauded the U.S. Food and Drug Administration (FDA) for adding a warning to long-acting or extended release opioid analgesics about the dangers of using these prescriptions during pregnancy.

The FDA made the change after being contacted by Attorney General Conway and 42 of his colleagues.  General Conway co-chairs the National Association of Attorneys General Substance Abuse Committee.

“I applaud the FDA for making this change that will better alert physicians and patients about the dangerous consequences of using these powerful prescription painkillers during pregnancy,” General Conway said.  “The warning labels on long-acting and extended release opioid analgesics are a good first step, and I hope similar labels will one day be included on all opioid prescriptions.”